Pharmaceutical and biotech companies invest billions of dollars in developing new treatments, yet many clinical trials face a costly and persistent challenge: patients dropping out of studies before they finish. While much attention is given to recruiting participants, keeping them engaged throughout the trial is equally vital to its success. When patients leave early, it can delay timelines, increase costs, reduce the reliability of results, and slow the development of new, potentially life-saving therapies. The reasons patients drop out are often more practical than people might expect. Clinical trial participants are not just patients—they are also parents, employees, students, and caregivers managing multiple responsibilities. When the demands of a trial, such as frequent clinic visits, long travel times, time away from work, childcare needs, or out-of-pocket expenses, become too much to manage, even those who are highly motivated may struggle to stay involved. These challenges, while individually manageable, can collectively become overwhelming for many people. To improve retention, the industry must rethink how it designs clinical trials. Too often, research has been structured around the needs of the institution rather than the realities of patients' daily lives. A truly patient-centered approach starts with asking: what barriers might prevent this person from participating successfully? The answer will vary for each individual. For some, it might be help with transportation. For others, it could be temporary housing, reimbursement for expenses, or the ability to conduct some study visits at home. These tailored solutions can make a significant difference in keeping patients engaged. Technology can play a valuable role in making trials more accessible and efficient, but it cannot solve every challenge. Patients often need flexibility, empathy, and personalized support when unexpected issues arise. While automated systems can handle routine tasks like processing claims, they may not understand the unique circumstances behind a patient’s situation. Human support teams are essential in providing the problem-solving, reassurance, and adaptability that technology alone cannot offer. Ultimately, clinical research must evolve to fit more naturally into patients' lives. By reducing the burden of participation and treating each person as an individual, the industry can improve retention, strengthen study results, and accelerate the delivery of new treatments to those in need.